News
Natus Vincere announces its comeback to Apex Legends with a new roster featuring ALGS 2024 champions from GoNext Esports and ...
4d
Stocktwits on MSNFDA Approves Mirum Pharmaceuticals’ Drug For Rare Liver Disease Patients In Tablet Form: Retail Stays BullishShares of Mirum Pharmaceuticals, Inc. (MIRM) were in the spotlight on Monday after the company announced that the U.S. Food ...
The inaugural ALGS Open is set to begin at the Ernest N. Morial Convention Center from May 1-4, 2025, marking what is ...
The Food and Drug Administration (FDA) has approved a tablet formulation of Livmarli ® (maralixibat).
The Global Series enters its next stage soon, with the ALGS 2025 open! What can we expect from the event when it begins?
NEW ORLEANS - New Orleans will become the epicenter of the esports universe when Electronic Arts (EA) hosts the Apex Legends ...
Nasdaq, S&P 500 Hit 6-Month Lows As Recession Fears Grow: What's Driving Markets Monday? Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the ...
10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever 60.4% of Aligos Therapeutics shares are held by institutional investors ...
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...
Under Takeda’s leadership, we are confident that LIVMARLI could have a meaningful impact on the lives of patients with ALGS and PFIC in Japan.” Mirum and Takeda entered into an exclusive ...
LIVMARLI Tablet formulation approved for patients with Alagille Syndrome (ALGS) and Progressive Familial Intrahepatic ...
S8UL, an Indian esports organization, marks a historic moment by entering the Apex Legends EWC 2025, becoming the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results